LNAI ▲ +4.3% - Lunai Bioworks Inc. $LNAI LNAI - Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement Lunai Bioworks rose 4.3% today following news that the company has expanded its Parkinson's disease platform through an exclusive agreement with Tanaist. The expansion of its therapeutic pipeline in a major neurological indication appears to have driven investor optimism in the stock. 22-SEP-2026 09:21 AM ET